Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for colorectal cancer

E Van Cutsem1, S Tejpar, P Rutgeerts

  • 1Department of Gastroenterology, University Hospital Gassthuisberg, Leuven, Belgium.

Acta Gastro-Enterologica Belgica
|September 1, 1995
PubMed
Summary

This review covers colorectal cancer screening methods like fecal occult blood testing and colonoscopy. It also addresses screening strategies for individuals at high risk of developing the disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation.

ESMO open·2026
Same author

Response to Letter to the Editor: 'NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial'.

ESMO open·2026
Same author

A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial.

ESMO open·2026
Same author

Managing adverse events in patients with metastatic colorectal cancer receiving trifluridine/tipiracil in combination with bevacizumab.

ESMO gastrointestinal oncology·2026
Same author

Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trial.

ESMO open·2025

Area of Science:

  • Gastroenterology and Oncology
  • Preventive Medicine
  • Diagnostic Imaging

Background:

  • Colorectal cancer (CRC) remains a significant health concern globally.
  • Early detection through screening is crucial for improving patient outcomes and survival rates.
  • Various screening modalities exist, each with its own advantages and limitations.

Purpose of the Study:

  • To review the current role of key colorectal cancer screening tests.
  • To evaluate the effectiveness of fecal occult blood testing, sigmoidoscopy, and total colonoscopy.
  • To discuss tailored screening strategies for high-risk patient populations.

Main Methods:

  • Literature review of existing studies and guidelines on colorectal cancer screening.
  • Comparative analysis of diagnostic accuracy and patient acceptance of different screening methods.
  • Discussion of risk stratification and management protocols for high-risk individuals.

Main Results:

  • Fecal occult blood testing (FOBT) is a non-invasive, cost-effective screening tool.
  • Sigmoidoscopy and total colonoscopy offer direct visualization but are more invasive.
  • Screening strategies for high-risk patients require individualized approaches based on specific risk factors.

Conclusions:

  • The choice of screening method should be individualized based on patient risk, preferences, and resource availability.
  • Combined strategies and regular surveillance are essential for effective colorectal cancer prevention.
  • Further research is needed to optimize screening protocols and address disparities in access and uptake.

Related Experiment Videos